Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Epigenetic Regulation01:37

Epigenetic Regulation

4.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.0K
Epigenetic Regulation01:46

Epigenetic Regulation

34.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NetCF: A Network Control-based Framework to Reveal the Molecular Mechanism of Phenotype Switching in Lung Cancer.

Genomics, proteomics & bioinformatics·2026
Same author

Srrm2 haploinsufficiency drives SynGAP-γ reduction, Agap3 mis-splicing, and oligodendrocyte deficits in a genetic mouse model of schizophrenia.

Cell reports·2026
Same author

Impaired removal of dying brain cells by microglia in Gpr34 deficient mice.

Journal of neuroinflammation·2026
Same author

Aberrant mRNA splicing and impaired hippocampal neurogenesis in <i>Grin2b</i> mutant mice.

iScience·2026
Same author

Elevated synaptic PKA activity and abnormal striatal dopamine signaling in <i>Akap11</i> mutant mice, a genetic model of schizophrenia and bipolar disorder.

bioRxiv : the preprint server for biology·2025
Same author

Elevated synaptic PKA activity and abnormal striatal dopamine signaling in Akap11 mutant mice, a genetic model of schizophrenia and bipolar disorder.

Nature communications·2025

Related Experiment Video

Updated: Mar 11, 2026

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
08:33

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Published on: March 24, 2019

8.0K

Epigenetic Changes in Neurodegenerative Diseases.

Min Jee Kwon1, Sunhong Kim2,3, Myeong Hoon Han1

  • 1Department of Brain & Cognitive Sciences, DGIST, Daegu 42988, Korea.

Molecules and Cells
|November 23, 2016
PubMed
Summary

Epigenetic changes, driven by protein toxicity, are increasingly recognized in neurodegenerative diseases like Alzheimer's disease. Modulating these epigenetic alterations offers potential therapeutic strategies.

Keywords:
epigenetic changeshistoneneurodegenerative diseasespost-translational modifications

More Related Videos

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.5K
Author Spotlight: Enhancements in Gene Expression Regulation Research
07:10

Author Spotlight: Enhancements in Gene Expression Regulation Research

Published on: September 15, 2023

2.7K

Related Experiment Videos

Last Updated: Mar 11, 2026

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
08:33

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Published on: March 24, 2019

8.0K
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.5K
Author Spotlight: Enhancements in Gene Expression Regulation Research
07:10

Author Spotlight: Enhancements in Gene Expression Regulation Research

Published on: September 15, 2023

2.7K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Neurodegenerative diseases exhibit complex neuronal pathology preceding significant cell loss.
  • Systemwide cellular changes, including epigenetic alterations, are implicated in neurodegeneration.
  • Protein toxicity is increasingly linked to epigenetic modifications in these conditions.

Purpose of the Study:

  • To review current understanding of epigenetic changes in Alzheimer's disease and polyglutamine diseases.
  • To explore the role of histone post-translational modifications (PTMs) in neurodegeneration.
  • To discuss the potential of epigenetic modulation as a therapeutic approach.

Main Methods:

  • Utilizing next-generation sequencing (NGS) to monitor histone PTMs.
  • Employing mass spectrometry to analyze PTMs and their link to transcriptional changes.
  • Reviewing existing literature on epigenetic alterations in neurodegenerative disease models.

Main Results:

  • Epigenetic alterations, specifically changes in histone PTMs, are associated with altered neuronal transcriptomes in neurodegenerative diseases.
  • These epigenetic changes are influenced by protein toxicity, a common factor in diseases like AD and polyQ disorders.
  • The study highlights the dynamic interplay between epigenetic modifications and cellular activity.

Conclusions:

  • Epigenetic dysregulation is a significant feature of neurodegenerative diseases such as Alzheimer's disease and polyglutamine diseases.
  • Targeting epigenetic mechanisms presents a promising avenue for future pharmaceutical interventions.
  • Further research into histone PTMs and their regulation can unlock novel therapeutic strategies.